9.1. Dissemination

As in the previous edition, the CPG will be distributed by post to interested professionals, and will be communicated at congresses and presented officially in public events. It will be necessary to contact mental health services of different autonomous communities and the corresponding scientific societies.

The dissemination strategy includes the following actions:

1. Ellaboration of press releases sent to the media, both scientific and general media.
2. Individual delivery to potential professional users of the CPG. A shorter format of the guideline and the most important annexes with algorithms and figures are also sent to these users.
3. Presentation to scientific societies and professional groups that are considered to be an objective sector of the public.
4. Indivualised distribution to opinion leaders and experts in accordance with criteria such as publication volume in scientific journals, presidency of scientific societies, members of the expert committees of biomedical journals, members of the scientific committees of congresses, etc.
5. Distribution of the guideline aimed at people with schizophrenia, and their families, friends or people they have a relationship with
6. Use of the CPC in adademic activities related to the methododlogy and development of CPGs.
7. Diffusion of the CPG in electronic format in the websites of the CAHTA and scientific societies.
8. Presentation of the CPG in scientific activities (conferences, congresses, meetings).
9. Publication of the CPG in medical journals.

9.2. Determination of implementation indicators

The objectives of implementing the CPG are:

1. - To provide a comprehensive approach for the management of patients with incipient psychosis or schizophrenia which includes pharmacological treatment; individual, group-based and family psychotherapy; and rehabilitation.
2. - To provide an adequate idiosyncratic combination of treatments of patients with incipient psychosis and schizophrenia.

The indicator designed to measure its scope is the percentage of patients with schizophrenia or incipient psychosis attended who have been offered pharmacological treatment; psychosocial intervention and rehabilitation, in accordance with the recommendations suggested in this CPG.